The human keratins: biology and pathology
- PMID: 18461349
- PMCID: PMC2386534
- DOI: 10.1007/s00418-008-0435-6
The human keratins: biology and pathology
Abstract
The keratins are the typical intermediate filament proteins of epithelia, showing an outstanding degree of molecular diversity. Heteropolymeric filaments are formed by pairing of type I and type II molecules. In humans 54 functional keratin genes exist. They are expressed in highly specific patterns related to the epithelial type and stage of cellular differentiation. About half of all keratins--including numerous keratins characterized only recently--are restricted to the various compartments of hair follicles. As part of the epithelial cytoskeleton, keratins are important for the mechanical stability and integrity of epithelial cells and tissues. Moreover, some keratins also have regulatory functions and are involved in intracellular signaling pathways, e.g. protection from stress, wound healing, and apoptosis. Applying the new consensus nomenclature, this article summarizes, for all human keratins, their cell type and tissue distribution and their functional significance in relation to transgenic mouse models and human hereditary keratin diseases. Furthermore, since keratins also exhibit characteristic expression patterns in human tumors, several of them (notably K5, K7, K8/K18, K19, and K20) have great importance in immunohistochemical tumor diagnosis of carcinomas, in particular of unclear metastases and in precise classification and subtyping. Future research might open further fields of clinical application for this remarkable protein family.
Figures






References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12121235', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12121235/'}]}
- Abrahams NA, Ormsby AH, Brainard J (2002) Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology 41(1):35–41 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14502799', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14502799/'}]}
- Abrahams NA, Bostwick DG, Ormsby AH, Qian J, Brainard JA (2003) Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. Am J Clin Pathol 120(3):368–376 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2874659', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2874659/'}]}
- Altmannsberger M, Dirk T, Droese M, Weber K, Osborn M (1986) Keratin polypeptide distribution in benign and malignant breast tumors: subdivision of ductal carcinomas using monoclonal antibodies. Virchows Arch B Cell Pathol Incl Mol Pathol 51(3):265–275 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1167052', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1167052/'}, {'type': 'PubMed', 'value': '2428612', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2428612/'}]}
- Bader BL, Magin TM, Hatzfeld M, Franke WW (1986) Amino acid sequence and gene organization of cytokeratin no. 19, an exceptional tail-less intermediate filament protein. EMBO J 5(8):1865–1875 - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '2465399', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2465399/'}]}
- Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE (1988) Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J Pathol 156(4):305–310 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials